Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08SND
|
||||
Former ID |
DIB020683
|
||||
Drug Name |
PF-543
|
||||
Synonyms |
sphingosine kinase 1 Inhibitor II; PF 543
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [541733] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H31NO4S
|
||||
InChI |
InChI=1S/C27H31NO4S/c1-21-14-24(20-33(30,31)27-7-3-2-4-8-27)16-26(15-21)32-19-23-11-9-22(10-12-23)17-28-13-5-6-25(28)18-29/h2-4,7-12,14-16,25,29H,5-6,13,17-20H2,1H3/t25-/m1/s1
|
||||
InChIKey |
NPUXORBZRBIOMQ-RUZDIDTESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sphingosine kinase | Target Info | Inhibitor | [531834] | |
BioCyc Pathway | Sphingosine and sphingosine-1-phosphate metabolism | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.